Gleevec holds potential as first drug to successfully treat neurofibromatosis
Thursday, October 30, 2008 - 15:07
in Health & Medicine
Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now.
